Cough, Cold and Allergy (Hay Fever) Remedies in China

September 2026

Cough, cold and allergy (hay fever) remedies in China is poised to display a notably weaker trajectory in 2026, with retail value falling by 4% to CNY58.2 billion, underperforming the broader Asia Pacific region where demand remains more resilient. This environment is shaped by contracting population figures, moderate GDP growth and shifting consumer behaviour towards precise, symptom-led shopping, moving away from the acute, pandemic-fuelled demand of recent years. While digital platforms and on-demand services have fundamentally redefined how products are accessed, the competitive landscape remains highly fragmented, with long-standing brands leveraging trust and broad distribution rather than disruptive innovation to maintain share. The overall outlook signals a challenging environment for new entrants, as established players with robust digital and logistics capabilities are best positioned to capture evolving demand, especially as product formats converge with fast-moving consumer goods and digital channels take centre stage. Brands seeking to succeed must prioritise product differentiation, investment in digital engagement and a deep understanding of the increasingly fragmented market landscape.

USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in China with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in China, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Cough, Cold and Allergy (Hay Fever) Remedies in China report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in China?
  • Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in China?
  • How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in China?
  • How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in China?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?

Key Data Insights

Key Industry Trends

Sales decline due to weaker seasonal outbreaks
Brands introduce gummies to capture demand for throat relief
Influenza A and digital consultation drive shift to targeted, immediate treatments
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Leading brands consolidate as demand shifts to targeted solutions
Allergy remedies outperform as medicated confectionery surges
Digital innovation, targeted treatments and cross-category competition reshape demand
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
CR Sanjiu leverages brand trust to reinforce its position
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintain their leadership due to high levels of consumer trust
Online platforms capture symptom-driven sales with O2O innovation
Chart 1 Retail Channels 2021-2026
Dingdang Health transforms allergy relief with instant digital access
Guangzhou Pharmaceutical captures younger consumers
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031

Country Reports Disclaimer

The following categories and subcategories are included:

Cough, Cold and Allergy (Hay Fever) Remedies

  • Antihistamines/Allergy Remedies (Systemic)
    • Paediatric Allergy Remedies
    • Paediatric Cough/Cold Remedies
  • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
  • Cough Remedies
    • Nasal Sprays
    • Oral Decongestants
    • Inhalant Decongestants
    • Decongestant Rubs
    • Nasal Decongestant Drops
    • Nasal Decongestant Plasters
  • Medicated Confectionery
  • Pharyngeal Preparations

Cough, Cold and Allergy (Hay Fever) Remedies

This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.

See all of our definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!